Plex Pharmaceuticals

company

About

Plex Pharmaceuticals a biotechnology company aiming at treating ALS,

  • 1 - 10

Details

Last Funding Type
Grant
Last Funding Money Raised
$1.60M
Industries
Biotechnology,Medical Device,Pharmaceutical
Founded date
Jan 1, 2009
Number Of Employee
1 - 10
Operating Status
Active

Plex's mission is to accelerate seminal academic discoveries into safe and effective treatments for unmet and under-served medical needs with a focus on neurodegenerative disorders.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$1.60M
Plex Pharmaceuticals has raised a total of $1.60M in funding over 2 rounds. Their latest funding was raised on Jul 8, 2020 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jul 8, 2020 Grant $1.60M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
Plex Pharmaceuticals is funded by 1 investors. National Institutes of Health are the most recent investors.
Investor Name Lead Investor Funding Round
National Institutes of Health Grant